U.S. Capital Markets Stock News

If you are staring at Fulton Financial’s ticker and wondering what comes next, you are not alone. The stock has quietly caught the eye of both cautious and optimistic investors after years of solid, if occasionally bumpy, performance. While volatility has crept in recently, with the price slipping -2.9% in the past week and -5.3% over the last month, the longer-term story is hard to ignore. Shares are up 10% over the past year, and an impressive 118.3% over five years, which suggests that...

Alto Neuroscience just received Fast Track designation from the FDA for ALTO-101, a new drug candidate aimed at treating cognitive impairment related to schizophrenia. This move could accelerate ALTO-101’s development and review process. See our latest analysis for Alto Neuroscience. The FDA’s support for ALTO-101 sparked fresh interest in Alto Neuroscience. However, despite the headline, its 1-year total shareholder return remains nearly flat while recent share price momentum has been...

Trying to decide what to do with Chemed stock right now? You are not alone. Shareholders and would-be investors alike have been watching the company’s journey with a mix of curiosity and concern. After all, Chemed’s story over the past year has not followed a gentle upward climb. Instead, it has seen some notable slides, including a 16.0% drop year-to-date and an even steeper 23.4% decline over the past 12 months. Even stretching out to five years, Chemed’s shares are down 5.9%, which can...

Thinking about your next move with American Homes 4 Rent? You are not alone. The real estate sector has kept investors guessing lately, and American Homes 4 Rent has seen its fair share of ups and downs. Over the past week, the stock held steady with a slight 0.1% bump, but the 30-day drop of 6.3% and a year-to-date slide of 11.2% might be giving some pause. Long-term holders have still netted a gain, with more than 22% over five years, but recent dips have many wondering whether there is...

In recent weeks, ProAssurance received a consensus "Hold" recommendation from six ratings firms, while Zacks Research raised its rating to "strong-buy" and institutional investors and hedge funds significantly increased their shareholdings. This combination of analyst upgrade and heightened institutional interest signals a shift in market sentiment and renewed confidence in the company’s outlook. We’ll examine how the increased institutional ownership may impact ProAssurance’s investment...

If you have been eyeing Slide Insurance Holdings or already hold some shares, you are probably wondering whether now is a smart time to buy, sell, or simply sit tight. The stock has certainly been on the move, with prices rising 5.2% over the past week and up 14.8% in the last month. That momentum stands in stark contrast to its year-to-date performance, where shares are still down 22.3%. This kind of turnaround often hints at shifting investor sentiment, possibly tied to developments in the...

Thinking about what to do with Informatica stock? You are not alone. Recent movement in the shares has caught a lot of attention, and there is no shortage of opinions out there. Right now, the stock is hovering near $24.92, and you might notice the numbers are a bit of a mixed bag. Over the past week and month, Informatica has inched up by 0.4% and 0.6% respectively, but if you look at the year-to-date performance, it is down 2.1%. The past year also shows a slight dip, with shares falling...

ClearPoint Neuro recently announced the appointment of Dr. Paul Larson as Chief Medical Officer, the unveiling of its proprietary Robotic Neuro-Navigation System for minimally invasive cranial procedures, and new insider buying from directors. The Robotic Neuro-Navigation System aims to provide greater consistency for cell and gene therapy delivery, and ClearPoint's drug delivery technology was spotlighted in strong Huntington's disease trial results from a biopharma collaborator. Let's...

Reitar Logtech Holdings recently announced the formal signing of a Strategic Cooperation Memorandum of Understanding with AI logistics company NEXX to jointly invest in a Smart Fulfillment Center project in Doha, Qatar, as part of broad plans for logistics automation in the region. This initiative not only launches a large-scale, AI-driven logistics facility but also aligns with Qatar's 2030 National Vision and the digital corridor ambitions of China's Belt and Road Initiative. We'll explore...

Trying to decide what to do with Miami International Holdings stock? You are not alone. With shares closing recently at $42.09, some investors are feeling bullish, while others are wondering if the momentum can last. Over the past seven days, the stock gained 2.1%, but the 30-day surge of 20.4% is what really has people talking. On a year-to-date basis, Miami International Holdings is up an impressive 36.9%. These kinds of moves often catch the eye of those looking for growth stories or...

If you have been watching Global-E Online's stock and trying to figure out what your next move should be, you are not alone. The company's journey has been anything but boring, with some investors feeling a bit whiplashed by the volatility. After rallying over the past few years, Global-E's share price just logged a 3.7% drop this week, and while the 1-year change sits at -3.3%, there is still that huge 39.3% gain when you look back three years. The downside is that year-to-date, the stock is...

With a price-to-earnings (or "P/E") ratio of 9.7x Green Brick Partners, Inc. ( NYSE:GRBK ) may be sending bullish...

With a median price-to-sales (or "P/S") ratio of close to 2.8x in the Medical Equipment industry in the United States...

The Glimpse Group, Inc. ( NASDAQ:VRAR ) shareholders would be excited to see that the share price has had a great...

Anyone interested in Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ) should probably be aware that the Co-Founder, Justin...

We wouldn't blame Snowflake Inc. ( NYSE:SNOW ) shareholders if they were a little worried about the fact that Vivek...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Over the last year, a good number of insiders have significantly increased their holdings in Neurogene Inc...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Blue Bird fair value estimate is US$94.98 Blue Bird is...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Key Insights Institutions' substantial holdings in Rayonier Advanced Materials implies that they have significant...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Stitch Fix fair value estimate is US$6.57 Stitch Fix is...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...